Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting

被引：0
作者：
Ahmet Emre Eskazan
机构：
[1] Istanbul University,Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukemia; Calcineurin Inhibitor; Lymphoid Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1537 / 1538
页数：1
相关论文
共 45 条
  • [21] Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer
    Matsue, Kosei
    Matsuo, Keitaro
    Fujiwara, Hideaki
    Iwama, Kan-ichi
    Hayama, Brian Y.
    Kimura, Shun-ichi
    Yamakura, Masayuki
    Takeuch, Masami
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (06) : 1170 - 1171
  • [22] Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
    Huan Chen
    Kai-yan Liu
    Lan-ping Xu
    Dai-hong Liu
    Yu-hong Chen
    Xiang-yu Zhao
    Wei Han
    Xiao-hui Zhang
    Yu Wang
    Yuan-yuan Zhang
    Ya-zhen Qin
    Yan-rong Liu
    Xiao-jun Huang
    Journal of Hematology & Oncology, 5
  • [23] Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
    Chen, Huan
    Liu, Kai-yan
    Xu, Lan-ping
    Liu, Dai-hong
    Chen, Yu-hong
    Zhao, Xiang-yu
    Han, Wei
    Zhang, Xiao-hui
    Wang, Yu
    Zhang, Yuan-yuan
    Qin, Ya-zhen
    Liu, Yan-rong
    Huang, Xiao-jun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [24] Ponatinib vs Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) ALL: PhALLCON Study
    Jabbour, Elias
    Martinelli, Giovanni
    Vignetti, Marco
    Ribera, Jose-Maria
    Gomez-Almaguer, David
    Minami, Yosuke
    Xu, Jing
    Srivastava, Shouryadeep
    Neumann, Frank
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S194 - S194
  • [25] Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
    Larson, R. A.
    Hochhaus, A.
    Hughes, T. P.
    Clark, R. E.
    Etienne, G.
    Kim, D-W
    Flinn, I. W.
    Kurokawa, M.
    Moiraghi, B.
    Yu, R.
    Blakesley, R. E.
    Gallagher, N. J.
    Saglio, G.
    Kantarjian, H. M.
    LEUKEMIA, 2012, 26 (10) : 2197 - 2203
  • [26] Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial
    Ashaye, Ajibade
    Shi, Ling
    Aldoss, Ibrahim
    Montesinos, Pau
    Vachhani, Pankit
    Rocha, Vanderson
    Papayannidis, Cristina
    Leonard, Jessica T.
    Baer, Maria R.
    Ribera, Jose-Maria
    McCloskey, James
    Wang, Jianxiang
    Gao, Sujun
    Rane, Deepali
    Guo, Shien
    LEUKEMIA, 2025, : 1342 - 1350
  • [27] Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy
    Alimena, Giuliana
    Breccia, Massimo
    Latagliata, Roberto
    Carmosino, Ida
    Russo, Eleonora
    Biondo, Francesca
    Diverio, Daniela
    Mancini, Marco
    Nanni, Mauro
    Mandelli, Franco
    CANCER, 2006, 107 (05) : 1008 - 1013
  • [28] Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
    R A Larson
    A Hochhaus
    T P Hughes
    R E Clark
    G Etienne
    D-W Kim
    I W Flinn
    M Kurokawa
    B Moiraghi
    R Yu
    R E Blakesley
    N J Gallagher
    G Saglio
    H M Kantarjian
    Leukemia, 2012, 26 : 2197 - 2203
  • [29] BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay
    Ono, Takaaki
    Miyawaki, Shuichi
    Kimura, Fumihiko
    Kanamori, Heiwa
    Ohtake, Shigeki
    Kitamura, Kunio
    Fujita, Hiroyuki
    Sugiura, Isamu
    Usuki, Kensuke
    Emi, Nobuhiko
    Tamaki, Shigehisa
    Aoyama, Yasutaka
    Kaya, Hiroyasu
    Naoe, Tomoki
    Tadokoro, Kenichi
    Yamaguchi, Toshikazu
    Ohno, Ryuzo
    Ohnishi, Kazunori
    LEUKEMIA RESEARCH, 2011, 35 (05) : 598 - 603
  • [30] Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lou, Yinjun
    Ma, Yafang
    Li, Chenyin
    Suo, Sansan
    Tong, Hongyan
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Yu, Wenjuan
    Mao, Liping
    Wei, Juyin
    Xu, Weilei
    Jin, Jie
    FRONTIERS OF MEDICINE, 2017, 11 (02) : 229 - 238
12345